Bupivacaine Injection, Suspension, Liposomal
Product Images NDC 57884-3252

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Bupivacaine (NDC 57884-3252). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Jiangsu Hengrui Pharmaceuticals Co., Ltd., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Bupivacaine 01)

Structure (Bupivacaine 01)
Chemical structure diagram of Bupivacaine, showing its molecular configuration including a piperidine ring attached to an amide group and an aromatic ring with methyl substitutions.*
FDA Label Image

Figure 1 (Bupivacaine 02)

Figure 1 (Bupivacaine 02)
A line graph comparing the pain index (PI) over time in hours between placebo and bupivacaine groups. The x-axis represents time in hours from 0 to 72, and the y-axis shows the pain index values. Two lines with error bars illustrate the trends for placebo (open circles) and bupivacaine (filled circles).*
FDA Label Image

03 (Bupivacaine 03)

03 (Bupivacaine 03)
Label for Bupivacaine Liposome Injectable Suspension 1.3% (133 mg/10 mL or 13.3 mg/mL) sterile injection in a 10 mL single dose vial. Intended for infiltration and interscalene brachial plexus nerve block only. Manufactured by Jiangsu Hengrui Pharmaceuticals Co., Ltd., China, and distributed by eVenus Pharmaceutical Laboratories, Inc., USA. Storage instructions and dosage information are noted.*
FDA Label Image

04 (Bupivacaine 04)

04 (Bupivacaine 04)
Label for Bupivacaine Liposome Injectable Suspension, 1.3% strength, 266 mg per 20 mL (13.3 mg/mL) in a 20 mL single dose vial. The label specifies use for infiltration and interscalene brachial plexus nerve block only, not for other routes of administration. It is manufactured by Jiangsu Hengrui Pharmaceuticals Co., Ltd., China, and distributed by eVenus Pharmaceutical Laboratories, Inc., USA.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.